SYL3C aptamer-anchored microemulsion co-loading β-elemene and PTX enhances the treatment of colorectal cancer

References

• Bodner SM, Minna JD, Jensen SM, et al. (1992). Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743–9.
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Bondarenko I, Hartmann,  et al. (2011). Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Anna Oncol 22:1535–46.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. (2014). Colorectal cancer. Lancet 383:1490–502.
   PubMed Web of Science ®Google Scholar
• Briscoe P, Caniggia I, Graves A, et al. (1995). Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am J Physiol 268:374–80.
   PubMed Web of Science ®Google Scholar
• Campos FC, Victorino VJ, Pinge MC, et al. (2014). Systemic toxicity induced by paclitaxel in vivo is associated with the solvent cremophor EL through oxidative stress-driven mechanisms. Food Chem Toxicol 68:78–86.
   PubMed Web of Science ®Google Scholar
• Cassidy J, Clarke SD, Az-Rubio E, et al. (2011). XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer 105:58–64.
   PubMed Web of Science ®Google Scholar
• Cheng KH. (1990). Headgroup hydration and motional order of lipids in lamellar liquid crystalline and inverted hexagonal phases of unsaturated phosphatidylethanolamine–a time-resolved fluorescence study. Chem Phys Lipids 53:191–202.
   PubMed Web of Science ®Google Scholar
• Dong P, Ma L, Liu L, et al. (2016). CD86+/CD206+, diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis. IJMS 17:320.
   Web of Science ®Google Scholar
• Fujii T, Tachibana M, Dhar DK, et al. (2003). Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice. Anticancer Res 23:2405–11.
   PubMed Web of Science ®Google Scholar
• Gu MJ, Huang QC, Bao CZ, et al. (2018). Attributable causes of colorectal cancer in China. BMC Cancer 18:38
   PubMed Web of Science ®Google Scholar
• Huang K, Vaughn DJ, Shaw LM, et al. (1998). A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer. Am J Clin Oncol 21:548–52.
   PubMed Web of Science ®Google Scholar
• Jiang S, Ling C, Li W, et al. (2016). Molecular mechanisms of anti-cancer activities of β-elemene: targeting hallmarks of cancer. ACAMC 16:1426–34.
   Web of Science ®Google Scholar
• Jiang Y, Liu G, Wang X, et al. (2015). Cytosol-specific fluorogenic reactions for visualizing intracellular disintegration of responsive polymeric nanocarriers and triggered drug release. Macromolecules 48:764–74.
   Web of Science ®Google Scholar
• Jing L, Ye Z, Qu J, et al. (2011). β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer 11:183.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Peereboom D, Buckwalter CA, et al. (1996). Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines. J Natl Cancer Inst 88:734–41.
   PubMed Web of Science ®Google Scholar
• Kim YS, Man BG. (2014). Advances in aptamer screening and small molecule aptasensors. Adv Biochem Eng Biotechnol 140:29–67.
   PubMed Web of Science ®Google Scholar
• Li QQ, Wang G, Zhang M, et al. (2009). beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22:161–70.
   PubMed Web of Science ®Google Scholar
• Li QQ, Wang G, Reed E, et al. (2010). Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol 107:868–76.
   PubMed Web of Science ®Google Scholar
• Madeddu C, Gramignano G, Kotsonis P, et al. (2018). Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6. Haematologica 103:e388–e391.
   PubMed Web of Science ®Google Scholar
• Masuda M, Kawakami S, Wijagkanalan W, et al. (2016). Anti-MUC1 aptamer/negatively charged amino acid dendrimer conjugates for targeted delivery to human lung adenocarcinoma A549 cells. Biol Pharm Bull 39:1734–8.
   PubMed Web of Science ®Google Scholar
• Meester RGS, Doubeni CA, Zauber AG, et al. (2015). Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer 81:AB181–AB182.
   Google Scholar
• Ming JL, Ding Q, Yan C, et al. (2016). Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo. Drug Deliv 23:3444–51.
   PubMed Web of Science ®Google Scholar
• Movahedi K, Laoui D, Gysemans C, et al. (2010). Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70:5728–39.
   PubMed Web of Science ®Google Scholar
• Munz M, Baeuerle PA, Gires O. (2009). The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69:5627–9.
   PubMed Web of Science ®Google Scholar
• Pearson JW, Fitzgerald DJ, Willingham MC, et al. (1989). Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice. Cancer Res 49:3562–7.
   PubMed Web of Science ®Google Scholar
• Qu D, He J, Liu C, et al. (2014). Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation. Int J Nanomedicine 9:109–19.
   PubMed Web of Science ®Google Scholar
• Qu D, Lin H, Zhang N, et al. (2013). In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. Carbohydr Polym 92:545–54.
   PubMed Web of Science ®Google Scholar
• Qu D, Ma Y, Sun W, et al. (2015). Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells. Int J Nanomedicine 2015, 1173–87.
   Google Scholar
• Qu D, Wang L, Liu M, et al. (2017). Oral nanomedicine based on multicomponent microemulsions for drug-resistant breast cancer treatment. Biomacromolecules 18:1268–80.
   PubMed Web of Science ®Google Scholar
• Qu D, Wang L, Qin Y, et al. (2018). Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion. Biomater Sci 6:3284–99.
   PubMed Web of Science ®Google Scholar
• Ratnasinghe D, Tangrea J, Roth MJ, et al. (1999). Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res 19:171–4.
   PubMed Web of Science ®Google Scholar
• Ruan LL, Wang DX, Zhang YW, et al. (2012). Different pH-values of release medium influence the drug release from PTX-PCL microspheres. AMR 482–484:2605–8.
   Google Scholar
• Sampson T. (2003). Aptamers and SELEX: the technology. World Pat Inf 25:123–9.
   Google Scholar
• Shigdar S, Lin J, Yu Y, et al. (2011). RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci 102:991–8.
   PubMed Web of Science ®Google Scholar
• Shin J, Shum P, Grey J, et al. (2012). Acid-labile mPEG–vinyl ether–1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics. Mol Pharmaceutics 9:3266–76.
   PubMed Web of Science ®Google Scholar
• Song Y, Zhu Z, An Y, et al. (2013). Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. Anal Chem 85:4141–9.
   PubMed Web of Science ®Google Scholar
• Stott SL, Hsu CH, Tsukrov DI, et al. (2010). Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 107:18392–7.
   PubMed Web of Science ®Google Scholar
• Strasser A, Harris AW, Huang DC, et al. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. Embo J 14:6136–47.
   PubMed Web of Science ®Google Scholar
• Su X, Gao C, Shi F, et al. (2017). A microemulsion co-loaded with schizandrin A–docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance. Drug Deliv 24:10–9.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Lau JY, Goh KL, Leung WK. (2005). Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6:871–6.
   PubMed Web of Science ®Google Scholar
• Wang G, Li X, Huang F, Zhao J, et al. (2005). Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. CMLS, Cell Mol Life Sci 62:881–93.
   PubMed Web of Science ®Google Scholar
• Xiao J, Chen Z, Li W, et al. (2015). Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial. Cancer Chemother Pharmacol 76:21–7.
   PubMed Web of Science ®Google Scholar
• Yi C, Zhong H, Tong S, et al. (2012). Enhanced oral bioavailability of a sterol-loaded microemulsion formulation of Flammulina velutipes, a potential antitumor drug. Int J Nanomed 7, 5067–78.
   PubMed Web of Science ®Google Scholar
• Ying P, Zhenxu L, Yi L, et al. (2015). Using DNA aptamer probe for immunostaining of cancer frozen tissues. Anal Chem 87:1919–24.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tian X, Cao X. (2019). Transferrin-functionalised microemulsion co-delivery of β-elemene and celastrol for enhanced anti-lung cancer treatment and reduced systemic toxicity. Drug Deliv Transl Res 9:667–78.
   PubMed Web of Science ®Google Scholar